Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

206.14 -7.67 (-3.59%)
Streaming Delayed Price Updated: 3:18 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
These S&P500 stocks are moving in today's session ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
ResMed (NYSE:RMD) Stock Dips Despite Q3 Earnings Beat and Strong Margin Growth ↗
Via Chartmill
Topics Earnings
ResMed Inc (NYSE:RMD): A Quality Dividend Stock Built on Strong Fundamentals ↗
Via Chartmill
ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength ↗
Via Chartmill
News headline image
RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 10.8% year on year to $1.43 bi... 
Via StockStory
Topics Economy Retirement
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
ResMed (RMD) Q3 2026 Earnings Transcript ↗
ResMed (RMD) Q3 2026 Earnings Transcript 
Via The Motley Fool
ResMed Inc. (NYSE:RMD) Emerges as a Prime Quality Investing Candidate ↗
Via Chartmill
ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗
Via Chartmill
Top S&P500 movers in Thursday's after hours session ↗
Via Chartmill
News headline image
ResMed’s (NYSE:RMD) Q1 CY2026 Sales Beat Estimates
Medical device company ResMed (NYSE:RMD) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 10.8% year on year to $1.43 billion... 
Via StockStory
Topics Earnings
News headline image
ResMed Earnings: What To Look For From RMD
Medical device company ResMed (NYSE:RMD) will be announcing earnings results this Thursday afternoon. Here’s what to look for. ResMed beat analysts’ revenue ... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income ↗
ResMed Inc. offers a sustainable dividend with a 10-year growth history, backed by strong profitability, a low payout ratio, and a rock-solid balance sheet for durable passive income. 
Via Chartmill
News headline image
Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence
News headline image
ResMed (RMD) Stock Trades Down, Here Is Why
What Happened? Shares of medical device company ResMed (NYSE:RMD) fell 2.6% in the afternoon session after its Chairman and CEO, Michael J. Farrell, sold sha... 
Via StockStory
Topics Economy
News headline image
3 Reasons Not to Sleep on ResMed Stock ↗
ResMed is a leader in CPAP machines and other medical devices that help millions breathe better. 
Via The Motley Fool
News headline image
3 Healthcare Stocks to Target This Week
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks
News headline image
3 Quality Compounders to Consider Right Now
Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous... 
Via StockStory
News headline image
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its... 
Via StockStory
Topics Earnings Economy
News headline image
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth
Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share... 
Via StockStory
Topics Economy
News headline image
ResMed (RMD) Q2 2026 Earnings Call Transcript ↗
ResMed (RMD) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.